Jubilant Pharmova Ltd

NSE: JUBLPHARMA · BSE: 530019 · Pharmaceuticals & Biotechnology · 29 announcements

Share price: ₹975.00
Market cap: ₹15,530 Cr
Revenue (annual): ₹8,280 Cr
Net profit (annual): ₹398.5 Cr
P/E (TTM): 44.1×Sector 47.4×
Promoter holding: 47.68%+0.00% QoQ
FII holding: 15.87%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Annual General Meeting 4 Legal & Regulatory 3 Other Announcement 2 Results Update 1 Production Started 1 Financial Results 1 Employee Stock Options 1 Business Update 1 Board Meeting Date 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

1 announcement with these filters

30 Jul 2026 17:45 IST BSE

Board Meeting Date

Jubilant Pharmova Board Meeting Date

Jubilant Pharmova Limited has scheduled a Board Meeting on August 07, 2026, to consider and approve the standalone and consolidated financial results for the quarter ended June 30, 2026.

Read the filing ↗